
Keywords: موش SCID; NPC; nasopharyngeal carcinoma; NPC-TW01,06 and 07; nasopharyngeal carcinoma, Taiwan, cell line-01, 06 and 07; C-P; control-peptide; L-P; L-peptide; Dox; doxorubicin; L-D; liposomal doxorubicin; L-P-L-D; L-peptide-linked liposomal doxorubicin; C-P-L-P; con